These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 29681510)

  • 1. Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia.
    Churchman ML; Qian M; Te Kronnie G; Zhang R; Yang W; Zhang H; Lana T; Tedrick P; Baskin R; Verbist K; Peters JL; Devidas M; Larsen E; Moore IM; Gu Z; Qu C; Yoshihara H; Porter SN; Pruett-Miller SM; Wu G; Raetz E; Martin PL; Bowman WP; Winick N; Mardis E; Fulton R; Stanulla M; Evans WE; Relling MV; Pui CH; Hunger SP; Loh ML; Handgretinger R; Nichols KE; Yang JJ; Mullighan CG
    Cancer Cell; 2018 May; 33(5):937-948.e8. PubMed ID: 29681510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
    Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
    Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ikaros: Exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia.
    Churchman ML; Mullighan CG
    Exp Hematol; 2017 Feb; 46():1-8. PubMed ID: 27865806
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Lopes BA; Barbosa TC; Souza BKS; Poubel CP; Pombo-de-Oliveira MS; Emerenciano M;
    Cancer Prev Res (Phila); 2017 Dec; 10(12):738-744. PubMed ID: 28947432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IKZF1 and CRLF2 gene alterations correlate with poor prognosis in Japanese BCR-ABL1-negative high-risk B-cell precursor acute lymphoblastic leukemia.
    Yamashita Y; Shimada A; Yamada T; Yamaji K; Hori T; Tsurusawa M; Watanabe A; Kikuta A; Asami K; Saito AM; Horibe K
    Pediatr Blood Cancer; 2013 Oct; 60(10):1587-92. PubMed ID: 23804397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature.
    Ruiz-Delgado GJ; Cantero-Fortiz Y; León-Peña AA; León-González M; Nuñez-Cortés AK; Ruiz-Argüelles GJ
    Rev Invest Clin; 2016; 68(4):210-4. PubMed ID: 27623040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IKAROS-Associated Diseases in 2020: Genotypes, Phenotypes, and Outcomes in Primary Immune Deficiency/Inborn Errors of Immunity.
    Kuehn HS; Nunes-Santos CJ; Rosenzweig SD
    J Clin Immunol; 2021 Jan; 41(1):1-10. PubMed ID: 33392855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional damaging germline variants in ETV6, IKZF1, PAX5 and RUNX1 predisposing to B-cell precursor acute lymphoblastic leukemia.
    Wagener R; Elitzur S; Brozou T; Borkhardt A
    Eur J Med Genet; 2023 Apr; 66(4):104725. PubMed ID: 36764385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan.
    Asai D; Imamura T; Suenobu S; Saito A; Hasegawa D; Deguchi T; Hashii Y; Matsumoto K; Kawasaki H; Hori H; Iguchi A; Kosaka Y; Kato K; Horibe K; Yumura-Yagi K; Hara J; Oda M;
    Cancer Med; 2013 Jun; 2(3):412-9. PubMed ID: 23930217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. It's ALL in the Family: IKZF1 and Hereditary Leukemia.
    Kamihara J; Shimamura A
    Cancer Cell; 2018 May; 33(5):798-800. PubMed ID: 29763621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan.
    Yang YL; Hung CC; Chen JS; Lin KH; Jou ST; Hsiao CC; Sheen JM; Cheng CN; Wu KH; Lin SR; Yu SL; Chen HY; Lu MY; Wang SC; Chang HH; Lin SW; Su YN; Lin DT
    Cancer Sci; 2011 Oct; 102(10):1874-81. PubMed ID: 21740479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ikaros and leukaemia.
    Olsson L; Johansson B
    Br J Haematol; 2015 May; 169(4):479-91. PubMed ID: 25753742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ikaros family zinc-finger 1 mutation is an independent factor for the poor prognosis of adult B-cell acute lymphoblastic leukemia, and allogeneic hematopoietic stem cell transplantation can improve clinical outcomes.
    Tang S; Shen H; Qu C; Dai H; Zhu X; Xue S; Ding Z; Lu J; Wu D; Tang X
    Bone Marrow Transplant; 2019 Feb; 54(2):236-243. PubMed ID: 29942002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of IKZF1 genetic alterations in adult patients with B-cell acute lymphoblastic leukemia.
    Tokunaga K; Yamaguchi S; Iwanaga E; Nanri T; Shimomura T; Suzushima H; Mitsuya H; Asou N
    Eur J Haematol; 2013 Sep; 91(3):201-208. PubMed ID: 23751147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia".
    Palmi C; Lana T; Silvestri D; Savino A; Kronnie GT; Conter V; Basso G; Biondi A; Valsecchi MG; Cazzaniga G
    Haematologica; 2013 Dec; 98(12):e164-5. PubMed ID: 24323991
    [No Abstract]   [Full Text] [Related]  

  • 16. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
    Mullighan CG; Su X; Zhang J; Radtke I; Phillips LA; Miller CB; Ma J; Liu W; Cheng C; Schulman BA; Harvey RC; Chen IM; Clifford RJ; Carroll WL; Reaman G; Bowman WP; Devidas M; Gerhard DS; Yang W; Relling MV; Shurtleff SA; Campana D; Borowitz MJ; Pui CH; Smith M; Hunger SP; Willman CL; Downing JR;
    N Engl J Med; 2009 Jan; 360(5):470-80. PubMed ID: 19129520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IKZF1
    Stanulla M; Dagdan E; Zaliova M; Möricke A; Palmi C; Cazzaniga G; Eckert C; Te Kronnie G; Bourquin JP; Bornhauser B; Koehler R; Bartram CR; Ludwig WD; Bleckmann K; Groeneveld-Krentz S; Schewe D; Junk SV; Hinze L; Klein N; Kratz CP; Biondi A; Borkhardt A; Kulozik A; Muckenthaler MU; Basso G; Valsecchi MG; Izraeli S; Petersen BS; Franke A; Dörge P; Steinemann D; Haas OA; Panzer-Grümayer R; Cavé H; Houlston RS; Cario G; Schrappe M; Zimmermann M; ;
    J Clin Oncol; 2018 Apr; 36(12):1240-1249. PubMed ID: 29498923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance.
    Vitanza NA; Zaky W; Blum R; Meyer JA; Wang J; Bhatla T; Morrison DJ; Raetz EA; Carroll WL
    Pediatr Blood Cancer; 2014 Oct; 61(10):1779-85. PubMed ID: 24976218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia.
    Marke R; van Leeuwen FN; Scheijen B
    Haematologica; 2018 Apr; 103(4):565-574. PubMed ID: 29519871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal hematopoiesis and autoimmunity in human subjects with germline IKZF1 mutations.
    Hoshino A; Okada S; Yoshida K; Nishida N; Okuno Y; Ueno H; Yamashita M; Okano T; Tsumura M; Nishimura S; Sakata S; Kobayashi M; Nakamura H; Kamizono J; Mitsui-Sekinaka K; Ichimura T; Ohga S; Nakazawa Y; Takagi M; Imai K; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S; Kojima S; Nonoyama S; Morio T; Kanegane H
    J Allergy Clin Immunol; 2017 Jul; 140(1):223-231. PubMed ID: 27939403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.